GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.8428
-0.0596 (-6.60%)
Apr 17, 2025, 4:00 PM EDT - Market closed
GeoVax Labs Revenue
In the year 2024, GeoVax Labs had annual revenue of $3.95M. GeoVax Labs had revenue of $864.42K in the quarter ending December 31, 2024.
Revenue (ttm)
$3.95M
Revenue Growth
n/a
P/S Ratio
1.09
Revenue / Employee
$232,622
Employees
17
Market Cap
11.48M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
GOVX News
- 22 days ago - GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - GlobeNewsWire
- 5 months ago - GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewsWire
- 5 months ago - GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 - GlobeNewsWire
- 7 months ago - GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 8 months ago - GeoVax to Participate in Upcoming Investor Conferences in September - GlobeNewsWire